Sleep Disorders Trial, Recruiting NCT06631976 Sponsor: Medical University of Lodz Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06631976
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a partial tear of a specific shoulder tendon (the supraspinatus), where the tear is smaller than 1 cm and affects less than half the tendon's thickness, confirmed by an ultrasound scan
  • People whose shoulder pain has been disrupting their sleep for at least 1 month, with a sleep quality score above 5 on a standard sleep questionnaire (called the PSQI)
  • People whose shoulder pain is specifically affecting the quality of their sleep
  • People with a body mass index (a measure of body weight relative to height) below 30
  • People aged between 40 and 75 years

Who may not be able to join:

  • People who have other sources of pain alongside their shoulder pain
  • People who have previously had surgery on their shoulder
  • People who have a psychiatric or neurological condition
  • People who have other health conditions known to affect sleep
  • People who have osteoporosis, diabetes, or high cholesterol, as these may affect healing and the risk of the injury getting worse
  • People who have alcohol dependence, nicotine addiction, or are regularly exposed to second-hand smoke
  • People currently taking certain antibiotics (fluoroquinolones), medications that affect sleep (such as melatonin, trazodone, or zolpidem), antidepressants, antipsychotics, or anti-anxiety medications
  • People who are unable or unwilling to give consent, are unable to cooperate, or have difficulty with verbal communication

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michał Kanak, MD, Medical University of Lodz

Phone: 178-334-0150

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Medical University of Lodz
Registry
ClinicalTrials.gov
Start date
4 June 2024
Est. completion
1 May 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Constant-Murley Score; Numeric pain Rating Scale; Range of motion measurements; Strength measurements; BDNF and proBDNF Assessment; Pittsburgh Sleep Quality Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov